Lista de obras -

Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients

artículo científico publicado en 2008

Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

scientific article published on 01 January 2011

Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b.

artículo científico publicado en 2012

Directly acting antivirals against hepatitis C virus

artículo científico publicado en 2011

Hepatitis B in HIV-infected patients

artículo científico

Hepatitis C therapy with HCV NS5B polymerase inhibitors

artículo científico publicado en 2013

Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver

artículo científico publicado en 2012

Host genetics.

artículo científico publicado en 2011

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

artículo científico publicado en 2011

Impact of baseline protease genotype and phenotype on the response to darunavir outside clinical trials

artículo científico publicado en 2007

Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.

artículo científico publicado en 2013

Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.

artículo científico publicado en 2011

Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user

artículo científico publicado en 2008

Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy

artículo científico

Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.

artículo científico publicado en 2010

Pharmacogenetics of hepatitis C.

artículo científico publicado en 2011

Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in Spain

artículo científico publicado en 2011

Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

artículo científico publicado en 2012

Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients

artículo científico publicado en 2010

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

artículo científico publicado en 2013

The changing face of hepatitis C in the new era of direct-acting antivirals.

artículo científico publicado en 2012

Treatment failure with new hepatitis C drugs

artículo científico

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C.

artículo científico publicado en 2013

Lista de obras de

Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients

Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b.

Directly acting antivirals against hepatitis C virus

Hepatitis B in HIV-infected patients

Hepatitis C therapy with HCV NS5B polymerase inhibitors

Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver

Host genetics.

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

Impact of baseline protease genotype and phenotype on the response to darunavir outside clinical trials

Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.

Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.

Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user

Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy

Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.

Pharmacogenetics of hepatitis C.

Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in Spain

Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

The changing face of hepatitis C in the new era of direct-acting antivirals.

Treatment failure with new hepatitis C drugs

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C.